Brief: Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against Astrazeneca
May 17 (Reuters) - AstraZeneca PLC AZN.L :
* PUMA BIOTECHNOLOGY INC - JURY VERDICT WAS ENTERED IN FAVOR
OF
WYETH, AND AGAINST ASTRAZENECA
* PUMA BIOTECHNOLOGY INC - JURY FOUND '314 & '162 PATENTS TO
BE
INFRINGED BY ASTRAZENECA AND NOT INVALID, AWARDED PLAINTIFFS
$107.5 MILLION IN DAMAGES
Source text for Eikon: ID:n0001437749-24-017504
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2